Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Chemistfrog

View Chemistfrog's StockTalks BY TICKER:
  • Chemistfrog
    $GLD I'm still bullish here! Will sell to reduce at $143 and $149, while holding rest w/trailing stop limits..
    Apr 28, 10:36 PM
    Reply (3)
  • View all 3 replies
    • Chemistfrog: LOL! How did NUGT go? Sold my $GLD at 142 when it appeared to be struggling and chart was looking scary... Considering a $JJC entry...
      May 4, 9:13 PM
    • Chemistfrog: Considering a 50/50 position mix in $GDX and $GDXJ, or adding $GLD back into the mix as well. Any opinions?
      May 6, 10:48 PM
      • Chemistfrog
        $SUPN I believe entry down here is wise. Q1 financials could really give the company momo.. Final approval for Trokendi in June/July
        Apr 20, 7:48 PM
        Reply (2)
        • joe kelly: You have any opinion on cytk? Keeps coming up on my radar along with supn.
          Apr 20, 8:05 PM
        • Chemistfrog: $CYTK chart is in breakout mode. Many catalysts ahead for 13. Watch earnings release for phase IIb update.. I like the company. Good future.
          Apr 20, 9:00 PM
          • Chemistfrog
            $ACRX simply looks "ready" :) Q2 data is imminent...
            Apr 20, 7:37 PM
            Reply
              • Chemistfrog
                $INO traded down due to poor data from collaborator using their own DNA. Updates on the company using their own DNA could really push it up
                Apr 20, 7:33 PM
                Reply
                  • Chemistfrog
                    $APPY sold off a bit last week and recovered Friday. I sold 1/2 into strength and am holding remainder..
                    Apr 20, 7:31 PM
                    Reply
                      • Chemistfrog
                        $CTSO is an exciting small company. Cytosorb is approved in Europe. Any IND filings for US clinicals would be huge..
                        Apr 20, 7:30 PM
                        Reply
                          • Chemistfrog
                            $AAPL is another one of those that I believe has been bashed down to current levels. I believe it wise to start accumulating here & lower..
                            Apr 20, 7:29 PM
                            Reply
                              • Chemistfrog
                                $TROV sold off last week. I accumulated a bit more as I can't believe it is down here. Looking for company updates..
                                Apr 20, 7:28 PM
                                Reply
                                  • Chemistfrog
                                    $SNRE still illiquid, but I believe it is HIGHLY UNDERVALUED. I have a small position but will add on any + clinical updates.
                                    Apr 20, 7:28 PM
                                    Reply
                                      • Chemistfrog
                                        $BIOD looking strong. I will continue to accumulate here, but would LOVE to see $2.50 before run up to September data release.
                                        Apr 20, 7:27 PM
                                        Reply
                                          • Chemistfrog
                                            $PAY I cannot see this dropping from these levels. watching to see if immediate inverse head-and-shoulders, bleed down or gradual recovery.
                                            Feb 21, 9:04 PM
                                            Reply
                                              • Chemistfrog
                                                $ACRX looks to be consolidating for the next leg up. Before or after 1Q data release? $DARA with many imminent catalysts
                                                Feb 5, 5:36 PM
                                                Reply
                                                  • Chemistfrog
                                                    EXEL should start getting a lot of serious attention going into 11/29 PDUFA cabozantinib. Priority review.. $EXEL
                                                    9/28/12
                                                    Reply
                                                      • Chemistfrog
                                                        $DCTH trading near its all-time low despite earnings and company update on August 7th and NDA re-filing in August.
                                                        8/4/12
                                                        Reply (1)
                                                        • nsahbti: Company updates usually keep stocks level until the news is out. you know, making sure there are no surprises. Just buy more if you think.
                                                          8/6/12
                                                          • Chemistfrog
                                                            $CHTP, way oversold once again on bad FDA news.... down but not out?!
                                                            7/3/12
                                                            Reply (1)
                                                            • Winning Will: agreed .. adding to my position at these sub 1.00 levels
                                                              7/3/12
                                                              • Chemistfrog
                                                                $CTSO.OB, I'm so surprised to see this trading near their 52-week low! Mark CE approval with solid science. U.S. trials likely next...
                                                                5/15/12
                                                                Reply (1)
                                                                • JosefK: What is Mark CE or CE Mark? Celenese is not your field.
                                                                  5/28/12
                                                                  • Chemistfrog
                                                                    ALXA, with the FDA panel's huge "book", it's no wonder FDA needs another 3 months!
                                                                    1/29/12
                                                                    Reply
                                                                      • Chemistfrog
                                                                        Watching immunotherapy cancer stock plays. Lots of potential there as evident by my last articles.
                                                                        1/29/12
                                                                        Reply
                                                                          • Chemistfrog
                                                                            Cormedix CRMD consolidation at this level. Several insider buys in December also. DD this before Monday. CE Mark 1H 2012. Cash thru 2012.
                                                                            12/24/11
                                                                            Reply
                                                                              • Chemistfrog
                                                                                CRMD, Cormedix, nice volume & consolidation last couple trading sessions. BIG 2012 AHEAD. CTSO.OB DARPA PR any day.. BPAX rebound to PDUFA?
                                                                                12/16/11
                                                                                Reply